Terms: = Bone cancer AND RARA, RAR, 5914, ENSG00000131759, NR1B1 AND Treatment
53 results:
1. ALDH1A1 drives prostate cancer metastases and radioresistance by interplay with AR- and rar-dependent transcription.
Gorodetska I; Offermann A; Püschel J; Lukiyanchuk V; Gaete D; Kurzyukova A; Freytag V; Haider MT; Fjeldbo CS; Di Gaetano S; Schwarz FM; Patil S; Borkowetz A; Erb HHH; Baniahmad A; Mircetic J; Lyng H; Löck S; Linge A; Lange T; Knopf F; Wielockx B; Krause M; Perner S; Dubrovska A
Theranostics; 2024; 14(2):714-737. PubMed ID: 38169509
[No Abstract] [Full Text] [Related]
2. rarγ: The bone of Contention for Endothelial Cells in Prostate cancer Metastasis.
Bhowmick S; Bhowmick NA
Cancer Res; 2022 Sep; 82(17):2975-2976. PubMed ID: 36052494
[TBL] [Abstract] [Full Text] [Related]
3. bone marrow overexpression of SNAI1 is an early indicator of intrinsic drug resistance in patients with de novo acute myeloid leukemia.
Gouda MBY; Hassan NM; Kandil EI
J Gene Med; 2023 May; 25(5):e3443. PubMed ID: 35900907
[TBL] [Abstract] [Full Text] [Related]
4. Retinoic Acid Receptor Activation Reduces Metastatic Prostate cancer bone Lesions by Blocking the Endothelial-to-Osteoblast Transition.
Yu G; Corn PG; Shen P; Song JH; Lee YC; Lin SC; Pan J; Agarwal SK; Panaretakis T; Pacifici M; Logothetis CJ; Yu-Lee LY; Lin SH
Cancer Res; 2022 Sep; 82(17):3158-3171. PubMed ID: 35802768
[TBL] [Abstract] [Full Text] [Related]
5. Identification of variant APL translocations PRKAR1A-rarα and ZBTB16-rarα (PLZF-rarα) through the MI-ONCOSEQ platform.
King D; Foucar CE; Ma V; Benitez L; Perissinotti AJ; Marini BL; Robinson D; Bhave RR; Bixby D
Cancer Genet; 2021 Nov; 258-259():57-60. PubMed ID: 34534739
[TBL] [Abstract] [Full Text] [Related]
6. Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience.
Boeri L; Sharma V; Kwon E; Stish BJ; Davis BJ; Karnes RJ
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):514-523. PubMed ID: 33268854
[TBL] [Abstract] [Full Text] [Related]
7. [Therapy-related acute promyelocytic leukemia developing during chemotherapy for thymic carcinoma].
Amino I; Maeda T; Aoki M; Kinoshita H; Muroya A; Taji Y; Kobayashi K; Okamura D; Murayama Y; Asou N; Ebihara Y
Rinsho Ketsueki; 2020; 61(8):874-878. PubMed ID: 32908049
[TBL] [Abstract] [Full Text] [Related]
8. Successful treatment of Therapy-related Acute Promyelocytic Leukemia with All-trans-retinoic acid Following Epirubicin for Hepatocellular Carcinoma and Docetaxel and Pembrolizumab Therapies for Lung Carcinoma: A Triple Malignancy Case.
Suzuki R; Kawai H; Furuya D; Akashi H; Ogawa Y; Kawada H; Ando K
Tokai J Exp Clin Med; 2020 Jul; 45(2):92-96. PubMed ID: 32602108
[TBL] [Abstract] [Full Text] [Related]
9. Fertility in female cancer survivors: a systematic review and meta-analysis.
Busnelli A; Vitagliano A; Mensi L; Acerboni S; Bulfoni A; Filippi F; Somigliana E
Reprod Biomed Online; 2020 Jul; 41(1):96-112. PubMed ID: 32456969
[TBL] [Abstract] [Full Text] [Related]
10. A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots.
Kárai B; Habók M; Reményi G; Rejtő L; Ujfalusi A; Kappelmayer J; Hevessy Z
Ann Hematol; 2019 Jun; 98(6):1413-1420. PubMed ID: 30830246
[TBL] [Abstract] [Full Text] [Related]
11. Amphiregulin enhances cell migration and resistance to doxorubicin in chondrosarcoma cells through the MAPK pathway.
Chen JC; Huang C; Lee IN; Wu YP; Tang CH
Mol Carcinog; 2018 Dec; 57(12):1816-1824. PubMed ID: 30230033
[TBL] [Abstract] [Full Text] [Related]
12. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro.
Noguera NI; Pelosi E; Angelini DF; Piredda ML; Guerrera G; Piras E; Battistini L; Massai L; Berardi A; Catalano G; Cicconi L; Castelli G; D'Angiò A; Pasquini L; Graziani G; Fioritoni G; Voso MT; Mastrangelo D; Testa U; Lo-Coco F
Oncotarget; 2017 May; 8(20):32550-32565. PubMed ID: 28427227
[TBL] [Abstract] [Full Text] [Related]
13. Dismal outcome of therapy-related myeloid neoplasm associated with complex aberrant karyotypes and monosomal karyotype: a case report.
Tang YL; Chia WK; Yap EC; Julia MI; Leong CF; Salwati S; Wong CL
Malays J Pathol; 2016 Dec; 38(3):315-319. PubMed ID: 28028303
[TBL] [Abstract] [Full Text] [Related]
14. rarα2 and PML-rar similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cells.
Gianni M; Fratelli M; Bolis M; Kurosaki M; Zanetti A; Paroni G; Rambaldi A; Borleri G; Rochette-Egly C; Terao M; Garattini E
Oncotarget; 2017 Jun; 8(23):37041-37060. PubMed ID: 27419624
[TBL] [Abstract] [Full Text] [Related]
15. Low-dose decitabine plus all-trans retinoic acid in patients with myeloid neoplasms ineligible for intensive chemotherapy.
Wu W; Lin Y; Xiang L; Dong W; Hua X; Ling Y; Li H; Yan F; Xie X; Gu W
Ann Hematol; 2016 Jun; 95(7):1051-7. PubMed ID: 27116384
[TBL] [Abstract] [Full Text] [Related]
16. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia.
Ouyang J; Goswami M; Tang G; Peng J; Ravandi F; Daver N; Routbort M; Konoplev S; Lin P; Medeiros LJ; Jorgensen JL; Wang SA
Am J Hematol; 2015 Jun; 90(6):504-10. PubMed ID: 25732229
[TBL] [Abstract] [Full Text] [Related]
17. Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL).
Kolhe R; Mangaonkar A; Mansour J; Clemmons A; Shaw J; Dupont B; Walczak L; Mondal A; Rojiani A; Jillella A; Kota V
Int J Lab Hematol; 2015 Aug; 37(4):515-20. PubMed ID: 25639817
[TBL] [Abstract] [Full Text] [Related]
18. Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-rarG leukemia.
Qiu JJ; Zeisig BB; Li S; Liu W; Chu H; Song Y; Giordano A; Schwaller J; Gronemeyer H; Dong S; So CW
Leukemia; 2015 May; 29(5):1153-62. PubMed ID: 25510432
[TBL] [Abstract] [Full Text] [Related]
19. Autologous is superior to allogeneic hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission.
Holter Chakrabarty JL; Rubinger M; Le-Rademacher J; Wang HL; Grigg A; Selby GB; Szer J; Rowe JM; Weisdorf DJ; Tallman MS
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1021-5. PubMed ID: 24691221
[TBL] [Abstract] [Full Text] [Related]
20. Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards.
Al-Kzayer LF; Uyen le TN; Al-Jadiry MF; Al-Hadad SA; Al-Badri SA; Ghali HH; Ameen NA; Liu T; Matsuda K; Abdulkadhim JM; Al-Shujairi TA; Matti ZI; Hasan JG; Al-Abdullah HM; Al-Ani MH; Saber PA; Khalil HM; Inoshita T; Kamata M; Koike K; Sakashita K
Ann Hematol; 2014 Jun; 93(6):949-55. PubMed ID: 24464319
[TBL] [Abstract] [Full Text] [Related]
[Next]